Professor
Catherine Birt
Ophthalmology & Vision Sciences
MD, FRCS(C)
Location
Sunnybrook Hospital
Address
2075 Bayview Ave, Suite M1 302a, Toronto, Ontario Canada M4N 3M5
Qualification
- Glaucoma Fellowship Wayne State University 1994
- Residency University of Toronto 1993
- FRCS(C) 1993
- MD University of Toronto 1989
- MA University of Toronto 1985
- BA (Hons) Queen's University at Kingston 1984
Recent Publications
- Hutnik C, Crichton A, Ford B, Saheb H, Shuba L, Birt C, Sogbesan E, Dorey M, Saheb H, Klar N, Guo H, Hodge W,. Selective laser trabeculoplasty versus argon laser trabeculoplasty in Glaucoma Patients Treated Previously with 360° selective laser trabeculoplasty: A randomized, single-blind, equivalence clinical trial. Ophthalmology, 2019;126:223-232.
- Aguayo Bonniard A, Yeung JY, Chan CC, Birt CM. Ocular surface toxicity from glaucoma topical medications and associated preservatives such as benzalkonium chloride (BAK). Expert opinion on Drug Metabolism and Toxicology., 2016;12:1279-1289.
- Boimer C, Birt CM. Preservative exposure and surgical outcomes in glaucoma patients: The PESO study. J Glaucoma. 2013; 22:730-735.
- Kent S, Hutnik CML. Birt CM, Damji KF, Harasymowycz P, Si F, Hodge WG, Pan IY, Crichton A. A randomized clinical trial of selective laser trabeculoplasty versus argon laser trabeculoplasty in patients with pseudoexfoliation. J. Glaucoma, 2013;24:344-347.
- Model of interprofessional collaboration in the care of glaucoma patients and glaucoma suspects. Can J Ophthalmol. 2011;46(6 Suppl):S1-21